0001437749-21-002282.txt : 20210209 0001437749-21-002282.hdr.sgml : 20210209 20210209101623 ACCESSION NUMBER: 0001437749-21-002282 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 504(b)(1) (not (i), (ii) or (iii)) FILED AS OF DATE: 20210209 DATE AS OF CHANGE: 20210209 EFFECTIVENESS DATE: 20210209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Luminary Therapeutics, Inc. CENTRAL INDEX KEY: 0001793860 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-388865 FILM NUMBER: 21604449 BUSINESS ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 BUSINESS PHONE: 612-309-7653 MAIL ADDRESS: STREET 1: 1621 E. HENNEPIN AVENUE STREET 2: SUITE 290 CITY: MINNEAPOLIS STATE: MN ZIP: 55414 D 1 primary_doc.xml X0708 D LIVE 0001793860 Luminary Therapeutics, Inc. 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 612-309-7653 DELAWARE None None Corporation true 2019 Jeff Liter 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Promoter David Largaespada 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Executive Officer Director Promoter John Wells 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Jim Haymaker 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Tracey Lodie 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director George Cox 1621 E. Hennepin Avenue Suite 290 Minneapolis MN MINNESOTA 55414 Director Biotechnology Decline to Disclose 04 false 2021-01-12 false true false 0 1000000 825000 175000 true 1 11 0 0 0 false Luminary Therapeutics, Inc. /s/ Jeff Liter Jeff Liter Chief Executive Officer 2021-02-08